Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.21.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Operating activities:    
Consolidated net income $ 202.9 $ 118.8
Adjustments to reconcile consolidated net income to net cash provided by operating activities:    
Depreciation and amortization 116.7 94.3
Stock-based compensation expense 20.7 18.8
Deferred income taxes 23.1 18.5
Loss (gain) on fair market value adjustment of equity investments 11.9 (32.9)
Gain on divestiture (0.2) 0.0
Changes in assets and liabilities, excluding effects of acquisitions:    
Accounts receivable, net (65.8) (83.9)
Other assets, current and long-term 14.7 29.6
Current and long term liabilities, excluding debt (180.6) (132.4)
Cash provided by operating activities 143.4 30.8
Investing activities:    
Capital expenditures (113.0) (88.0)
Acquisitions, net of cash acquired (862.0) (48.1)
Cash received from divestiture 1.5 0.0
Cash used in investing activities (973.5) (136.1)
Financing activities:    
Net short-term borrowings (0.7)  
Net short-term borrowings   0.2
Borrowings on long-term debt 0.0 125.0
Treasury stock purchases (34.1) 0.0
Dividends paid to Equifax shareholders (47.5) (47.3)
Dividends paid to noncontrolling interests (0.7) (0.3)
Proceeds from exercise of stock options and employee stock purchase plan 6.6 16.7
Payment of taxes related to settlement of equity awards (8.6) 0.0
Purchase of redeemable noncontrolling interests (3.6) 0.0
Debt issuance costs 0.0 (1.6)
Cash (used in) provided by financing activities (88.6) 92.7
Effect of foreign currency exchange rates on cash and cash equivalents 0.0 (18.8)
Decrease in cash and cash equivalents (918.7) (31.4)
Cash and cash equivalents, beginning of period 1,684.6 401.3
Cash and cash equivalents, end of period $ 765.9 $ 369.9